Pinto-Mariz, Fernanda Rodrigues Carvalho, Luciana Prufer De Queiroz Campos Araujo, Alexandra De Mello, Wallace Gonçalves Ribeiro, Mårcia Cunha, Maria Cabello, Pedro Riederer, Ingo Negroni, Elisa Desguerre, Isabelle Veras, Mariana Yada, Erica Allenbach, Yves Benveniste, Olivier Voit, Thomas Mouly, Vincent Silva-Barbosa, Suse Butler-Browne, Gillian Savino, Wilson Additional file 5: Figure S2. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy Lack of differences between DMD patients and healthy control in relative numbers of CD14/CD49dhi and CD19/CD49dhi cells. (DOC 69 kb) Duchenne muscular dystrophy;Inflammation;CD49d;T lymphocytes;Predictive biomarker;Immunotherapy 2015-12-10
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_5_Figure_S2_of_CD49d_is_a_disease_progression_biomarker_and_a_potential_target_for_immunotherapy_in_Duchenne_muscular_dystrophy/4375850
10.6084/m9.figshare.c.3615224_D2.v1